Craig A. Erickson, M.D.

Associate Professor, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine

SFARI Investigator Website

Craig A. Erickson specializes in research and clinical treatment involving persons with developmental disorders. His primary research focus is on new treatment development for fragile X syndrome, autism spectrum disorders and other related disorders.

Erickson is the director of the Fragile X Research and Treatment Center and also serves as the director of research at the Kelly O’Leary Center for Autism Spectrum Disorders.

Funded Projects

SPARK

Awarded: 2016
Award Type: SPARK

Developing an ERK biomarker for autism

Awarded: 2012
Award Type: Research

SFARI Funded Publications

Characterization of medication use in a multicenter sample of pediatric inpatients with autism spectrum disorder. Wink L.K., Pedapati E.V., Adams R., Erickson C. A., Pedersen K.A., Morrow E., Kaplan D., Siegel M., Autism and Developmental Disabilities Inpatient Research Collaborative (ADDIRC).

Impaired perceptual learning in a mouse model of fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible. Goel A., Cantu D.A., Guilfoyle J., Chaudhari G.R., Newadkar A., Todisco B., de Alba D., Kourdougli N., Schmitt L.M., Pedapati E., Erickson C. A., Portera-Cailliau C.

The autism inpatient collection: Methods and preliminary sample description. Siegel M., Smith K., Mazefsky C., Gabriels R.L., Erickson C. A., Kaplan D., Morrow E., Wink L., Santangelo S.L., Autism and Developmental Disorders Inpatient Research Collaborative (ADDIRC).

Research Highlight